Low-Dose Aspirin Upregulates Tyrosine Hydroxylase and Increases Dopamine Production in Dopaminergic Neurons: Implications for Parkinson's Disease
- PMID: 30187283
- PMCID: PMC6401361
- DOI: 10.1007/s11481-018-9808-3
Low-Dose Aspirin Upregulates Tyrosine Hydroxylase and Increases Dopamine Production in Dopaminergic Neurons: Implications for Parkinson's Disease
Erratum in
-
Correction: Low-Dose Aspirin Upregulates Tyrosine Hydroxylase and Increases Dopamine Production in Dopaminergic Neurons: Implications for Parkinson's Disease.J Neuroimmune Pharmacol. 2025 Mar 26;20(1):28. doi: 10.1007/s11481-025-10189-3. J Neuroimmune Pharmacol. 2025. PMID: 40138106 No abstract available.
Abstract
Increasing the function of residual dopaminergic neurons in the nigra of PD patients is an important area of research as it may eventually compensate the loss. Although tyrosine hydroxylase (TH) is the rate-limiting enzyme in the dopamine (DA) biosynthesis pathway, there are no effective drugs/molecules to upregulate TH and increase the production of DA in nigral dopaminergic neurons. This study underlines the importance of aspirin in stimulating the expression of TH and increasing the level of DA in dopaminergic neurons. At low doses, aspirin increased the expression of TH and the production of DA in mouse MN9D dopaminergic neuronal cells. Accordingly, oral administration of aspirin increased the expression of TH in the nigra and upregulated the level of DA in striatum of normal C57/BL6 mice and aged A53T α-syn transgenic mice. Oral aspirin also improved locomotor activities of normal mice and A53T transgenic mice. While investigating mechanisms, we found the presence of cAMP response element (CRE) in the promoter of TH gene and the rapid induction of cAMP response element binding (CREB) activation by aspirin in dopaminergic neuronal cells. Aspirin treatment also increased the level of phospho-CREB in the nigra of C57/BL6 mice. The abrogation of aspirin-induced expression of TH by siRNA knockdown of CREB and the recruitment of CREB to the TH gene promoter by aspirin suggest that aspirin stimulates the transcription of TH in dopaminergic neurons via CREB. These results highlight a new property of aspirin in stimulating the TH-DA pathway, which may be beneficial in PD patients. Graphical Abstract ᅟ.
Keywords: Aspirin; CREB; Dopamine; Striatum; Substantia nigra pars compacta; Tyrosine hydroxylase.
Conflict of interest statement
Figures









Similar articles
-
Cell senescence induced by toxic interaction between α-synuclein and iron precedes nigral dopaminergic neuron loss in a mouse model of Parkinson's disease.Acta Pharmacol Sin. 2024 Feb;45(2):268-281. doi: 10.1038/s41401-023-01153-z. Epub 2023 Sep 6. Acta Pharmacol Sin. 2024. PMID: 37674042 Free PMC article.
-
Early α-synuclein/synapsin III co-accumulation, nigrostriatal dopaminergic synaptopathy and denervation in the MPTPp mouse model of Parkinson's Disease.Exp Neurol. 2025 Jan;383:115040. doi: 10.1016/j.expneurol.2024.115040. Epub 2024 Nov 3. Exp Neurol. 2025. PMID: 39500391
-
Downregulation of tyrosine hydroxylase phenotype after AAV injection above substantia nigra: Caution in experimental models of Parkinson's disease.J Neurosci Res. 2019 Mar;97(3):346-361. doi: 10.1002/jnr.24363. Epub 2018 Dec 12. J Neurosci Res. 2019. PMID: 30548446 Free PMC article.
-
RGS Proteins as Critical Regulators of Motor Function and Their Implications in Parkinson's Disease.Mol Pharmacol. 2020 Dec;98(6):730-738. doi: 10.1124/mol.119.118836. Epub 2020 Feb 3. Mol Pharmacol. 2020. PMID: 32015009 Free PMC article. Review.
-
Calpain activation and progression of inflammatory cycles in Parkinson's disease.Front Biosci (Landmark Ed). 2022 Jan 13;27(1):20. doi: 10.31083/j.fbl2701020. Front Biosci (Landmark Ed). 2022. PMID: 35090325 Free PMC article. Review.
Cited by
-
Upregulation of DJ-1 in Dopaminergic Neurons by a Physically-Modified Saline: Implications for Parkinson's Disease.Int J Mol Sci. 2023 Feb 28;24(5):4652. doi: 10.3390/ijms24054652. Int J Mol Sci. 2023. PMID: 36902085 Free PMC article.
-
Nebulization of low-dose aspirin ameliorates Huntington's pathology in N171-82Q transgenic mice.NeuroImmune Pharm Ther. 2024 Feb 9;3(1):47-59. doi: 10.1515/nipt-2023-0026. eCollection 2024 Mar. NeuroImmune Pharm Ther. 2024. PMID: 38532785 Free PMC article.
-
In Vivo Metabolic Response upon Exposure to Gold Nanorod Core/Silver Shell Nanostructures: Modulation of Inflammation and Upregulation of Dopamine.Int J Mol Sci. 2020 Jan 8;21(2):384. doi: 10.3390/ijms21020384. Int J Mol Sci. 2020. PMID: 31936206 Free PMC article.
-
Moxibustion Protects Dopaminergic Neurons in Parkinson's Disease through Antiferroptosis.Evid Based Complement Alternat Med. 2021 Apr 16;2021:6668249. doi: 10.1155/2021/6668249. eCollection 2021. Evid Based Complement Alternat Med. 2021. PMID: 34122606 Free PMC article.
-
First-in-Human PET Imaging of [18F]SDM-4MP3: A Cautionary Tale.Mol Imaging. 2023 Sep 8;2023:8826977. doi: 10.1155/2023/8826977. eCollection 2023. Mol Imaging. 2023. PMID: 37719326 Free PMC article.
References
-
- Aubin N, Curet O, Deffois A, Carter C (1998) Aspirin and salicylate protect against MPTP-induced dopamine depletion in mice. J Neurochem 71:1635–1642. - PubMed
-
- Belgacem YH, Borodinsky LN (2017) CREB at the Crossroads of Activity-Dependent Regulation of Nervous System Development and Function. Adv Exp Med Biol 1015:19–39. - PubMed
-
- Benner EJ, Mosley RL, Destache CJ, Lewis TB, Jackson-Lewis V, Gorantla S, Nemachek C, Green SR, Przedborski S, Gendelman HE (2004) Therapeutic immunization protects dopaminergic neurons in a mouse model of Parkinson’s disease. Proceedings of the National Academy of Sciences of the United States of America 101:9435–9440. - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous